Most people on Mounjaro lose between 15% and 22% of their body weight over about 72 weeks, depending on their dose. For someone starting at 250 pounds, that translates to roughly 40 to 55 pounds over a year and a half. The loss isn’t evenly distributed, though. It comes faster in the early months, slows as your dose increases, and eventually levels off at a plateau.
What the Clinical Trials Found
The largest trial studying Mounjaro for weight loss, called SURMOUNT-1, tested three doses in adults with obesity or overweight. After 72 weeks, people on the 5 mg dose lost an average of 16% of their body weight. Those on 10 mg lost 21.4%, and the 15 mg group lost 22.5%. The placebo group lost about 3%.
For people with type 2 diabetes, the results were more modest. In a separate trial, the highest dose produced an average weight loss of 14.7% over 72 weeks. Diabetes changes how the body responds to the medication, which partly explains the difference.
These are averages, and individual results vary widely. The trials identified two distinct groups: early responders, who lost an average of 23.2 kg (about 51 pounds) by week 72, and late responders, who lost about 12 kg (26 pounds) over the same period. Late responders took an average of nearly 25 weeks just to reach 5% weight loss, while early responders hit that milestone much sooner.
How the Dosing Schedule Shapes Your Timeline
You don’t start on a full dose. Mounjaro begins at 2.5 mg per week, a dose that’s purely for getting your body adjusted. Every four weeks, the dose increases by 2.5 mg until you reach your target, which can be 5 mg, 10 mg, or 15 mg. That means reaching the maximum dose takes at least 20 weeks of gradual increases.
Weight loss tends to accelerate as the dose goes up. Most of the early weeks are spent adjusting, so dramatic changes in the first month or two are uncommon. The real momentum builds once you’ve settled into a higher maintenance dose. Side effects, mostly nausea and digestive issues, are most common during the dose increases and tend to ease once you stabilize.
When Weight Loss Levels Off
Mounjaro doesn’t produce unlimited weight loss. Your body eventually reaches a new equilibrium. Researchers defined a plateau as any point where weight changed less than 5% over a 12-week window and stayed that way.
The timeline to plateau depends heavily on how much weight you have to lose. People with overweight or class I obesity (lower starting BMIs) hit their plateau around 24 to 26 weeks. Those with class II or class III obesity took longer, reaching plateau around 36 weeks. Higher doses, younger age, and being female were all associated with a later plateau, meaning more total time spent actively losing weight before things stabilized.
By week 72, the vast majority of participants had plateaued regardless of their starting weight. This doesn’t mean the medication stopped working. It means your body reached a lower, stable weight that the drug helps maintain.
How Mounjaro Compares to Other Weight Loss Drugs
Mounjaro works differently from older weight loss medications and even from its closest competitor, semaglutide (sold as Wegovy and Ozempic). While semaglutide acts on a single gut hormone receptor, Mounjaro targets two: GLP-1 and GIP. This dual action produces a stronger effect on appetite, insulin response, and fat metabolism. In animal studies, activating both receptors together reduced body weight and food intake more than activating either one alone.
The clinical results reflect this. The 20 to 22% body weight reduction seen with Mounjaro’s highest dose exceeds what semaglutide trials have typically reported, which tends to land around 15% at comparable timepoints.
What You’re Actually Losing
Not all the weight that comes off is fat. In a detailed body composition substudy, about 75% of the weight lost on Mounjaro came from fat mass and 25% from lean mass, which includes muscle. Women lost roughly 6.9% of their lean mass over a year, while men lost about 5.5%.
Those numbers sound concerning, but researchers compared them to normal patterns of lean mass change in the general population and found they fell within expected ranges. In other words, the muscle loss was proportional to the overall weight loss, not excessive. Still, resistance training during treatment is a practical way to preserve muscle, especially if you’re losing weight quickly or are over 50.
Realistic Expectations by Month
Putting the trial data into a rough monthly timeline gives a clearer picture of what to expect. During the first one to two months, you’re on the starter dose. Weight loss is minimal, often just a few pounds. Months two through four bring the first noticeable changes as your dose increases and appetite suppression kicks in. The fastest period of loss for most people falls between months three and six, when higher doses are taking full effect and the body hasn’t yet adapted.
After about six to nine months, the rate of loss starts to slow. By 12 to 18 months, most people have reached or are approaching their plateau. The total amount lost depends on your starting weight, your dose, and how your body responds. A person starting at 300 pounds on the highest dose might realistically lose 60 to 70 pounds. Someone starting at 200 pounds might lose 30 to 40.
Why Results Vary So Much
The gap between early and late responders in the trials was substantial: a difference of more than 25 pounds in total weight lost. Several factors influence which group you fall into. Starting BMI matters, as does whether you have type 2 diabetes (which typically slows loss). Your dose plays a significant role, with higher doses producing greater loss on average. Age and sex also affect the timeline, with younger women tending to lose weight over a longer active period before plateauing.
Diet and physical activity still matter on Mounjaro. The clinical trials all included reduced-calorie diets and exercise as part of the protocol. The medication makes it easier to eat less by reducing hunger and slowing digestion, but it works best as part of broader lifestyle changes rather than as a standalone fix.